Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $86.7514 (-0.95%) ($84.4819 - $88.5422) on Tue. Apr. 3, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.11% (three month average) | RSI | 10 | Latest Price | $86.7514(-0.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1% a day on average for past five trading days. | Weekly Trend | ABBV declines -10.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(48%) SPLV(48%) IWD(47%) | Factors Impacting ABBV price | ABBV will decline at least -1.555% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) DIA(-7%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.555% (StdDev 3.11%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
1 - 5 Day Possible Target | $73.35(-15.45%) | Resistance Level | $101.97 | 5 Day Moving Average | $88.67(-2.16%) | 10 Day Moving Average | $93.35(-7.07%) | 20 Day Moving Average | $101.97(-14.92%) | To recent high | -26.5% | To recent low | 0% | Market Cap | $153.054b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |